Drug intelligence / Profile preview

Pharmaton

Development stage
Unknown
Lead developer
Pharmaton
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Pharmaton is a standardized multivitamin and mineral supplement characterized by the inclusion of standardized Panax ginseng extract G115 and deanol (2-dimethylaminoethanol). Originally developed by Pharmaton SA and later managed by Boehringer Ingelheim and Sanofi, it is indicated for the relief of daily fatigue, exhaustion, and the improvement of mental and physical performance. The deanol component acts as a precursor to acetylcholine, a neurotransmitter essential for cognitive functions such as concentration and memory. The G115 ginseng extract acts as an adaptogen, helping the body manage stress by modulating the hypothalamic-pituitary-adrenal (HPA) axis and improving cellular energy utilization. While many modern formulations of Pharmaton (such as Pharmaton Vitality) have removed deanol to comply with changing dietary supplement regulations in various regions, the deanol-containing version remains a recognized medicinal product in numerous international markets.

Brand names
Pharmaton CapsulesPharmaton Capsules with Selenium
Other names
Pharmaton with DeanolPharmaton with DMAEGinseng G115 + Deanol + Multivitamins
02

Targets

CHAT (Choline acetyltransferase)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Pharmaton.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmaton.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call